{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T03:55:47Z","timestamp":1783137347759,"version":"3.54.6"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"38","license":[{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9,22]]},"abstract":"<jats:p>Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide. Observational studies have revealed various risk factors associated with NAFLD, while the causal relationships between NAFLD and clinical diseases (including obesity, diabetes and inflammation) remain unclear. In this study, based on the genome-wide association study (GWAS) data, a two-sample Mendelian randomization (MR) analysis was conducted to evaluate the causality between NAFLD and 6 clinical indicators, including body mass index (BMI), waist-to-hip ratio (WHR), C-reactive protein (CRP), fasting blood glucose (FG), fasting insulin (FI), and glycosylated hemoglobin (HbA1c). MR is based on Mendel\u2019s law of inheritance, which uses genetic variation as a toll variable to affect the health of a population to infer causal effects in the presence of unobserved confounding. Inverse variance weighted method was the main MR method. In addition, we performed multiple steps of variable screening in the method to ensure that we were conducting the study under the MR assumption. In the MR analysis, a higher WHR (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.0078; OR\u2005=\u20051.008; 95% CI, 1.002\u20131.013) was genetically predicted to be causally associated with an increased risk of NAFLD, while patients with higher HbA1c had a lower risk of NAFLD (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.0437; OR\u2005=\u20050.44; 95% CI, 0.20\u20130.97). Our results showed that the genetically driven WHR and HbA1c might be potential causal factors for NAFLD, while BMI, FG, FI, and CRP were not causal factors for NAFLD, which explained the promoting role of WHR and HbA1c in the occurrence and development of NAFLD. Our finding hence revealed new insights into how nature and nurture factors underpin NAFLD, providing positive effect on the causes and prevention of this disease.<\/jats:p>","DOI":"10.1097\/md.0000000000034638","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T12:43:36Z","timestamp":1695645816000},"page":"e34638","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Mendelian randomization explores the causal relationships between obesity, diabetes, inflammation and nonalcoholic fatty liver disease"],"prefix":"10.1097","volume":"102","author":[{"given":"Xing","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Weifang Medical University, Weifang, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianpeng","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Weifang Medical University, Weifang, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichao","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Weifang Medical University, Weifang, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Weifang Medical University, Weifang, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Weifang Medical University, Weifang, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9197-0843","authenticated-orcid":false,"given":"Chao","family":"Geng","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Weifang Medical University, Weifang, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","article-title":"NAFLD, NASH and liver cancer.","volume":"10","author":"Michelotti","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes.","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study.","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review.","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention.","volume":"18","author":"Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"R8-20250504","first-page":"1","article-title":"Definitions, classification, and epidemiology of obesity.","author":"Purnell","year":"2018","journal-title":"Endotext"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"e1003100","DOI":"10.1371\/journal.pmed.1003100","article-title":"Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of population-based observational studies.","volume":"17","author":"Jarvis","year":"2020","journal-title":"PLoS Med"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"194","DOI":"10.25122\/jml-2018-0031","article-title":"The role of anthropometric indices in the prediction of non-alcoholic fatty liver disease in the PERSIAN Guilan Cohort study (PGCS).","volume":"11","author":"Mansour-Ghanaei","year":"2018","journal-title":"J Med Life"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-018-0913-3","article-title":"A longitudinal epidemiological study on the triglyceride and glucose index and the incident nonalcoholic fatty liver disease.","volume":"17","author":"Zheng","year":"2018","journal-title":"Lipids Health Dis"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/met.2020.0109","article-title":"Triglyceride glucose index and related parameters (triglyceride glucose-body mass index and triglyceride glucose-waist circumference) identify nonalcoholic fatty liver and liver fibrosis in individuals with overweight\/obesity.","volume":"19","author":"Khamseh","year":"2021","journal-title":"Metab Syndr Relat Disord"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-019-0986-7","article-title":"Triglycerides to high-density lipoprotein cholesterol ratio as a surrogate for nonalcoholic fatty liver disease: a cross-sectional study.","volume":"18","author":"Fan","year":"2019","journal-title":"Lipids Health Dis"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3390\/ijerph18030857","article-title":"Gender differences in the relationships among metabolic syndrome and various obesity-related indices with nonalcoholic fatty liver disease in a Taiwanese population.","volume":"18","author":"Lin","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"6678755","DOI":"10.1155\/2021\/6678755","article-title":"Evaluation of different anthropometric indicators for screening for nonalcoholic fatty liver disease in elderly individuals.","volume":"2021","author":"Zhang","year":"2021","journal-title":"Int J Endocrinol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S2468-1253(21)00275-2","article-title":"Epidemiology, risk factors, social determinants of health, and current management for non-alcoholic fatty liver disease in sub-Saharan Africa.","volume":"6","author":"Spearman","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis.","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/gutjnl-2020-322572","article-title":"Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals.","volume":"70","author":"Mantovani","year":"2021","journal-title":"Gut"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"dgaa583","DOI":"10.1210\/clinem\/dgaa583","article-title":"Nonalcoholic fatty liver disease and estimated insulin resistance in obese youth: a Mendelian randomization analysis.","volume":"105","author":"Morandi","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/liv.13185","article-title":"Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?","volume":"36","author":"Valenti","year":"2016","journal-title":"Liver Int"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"113888","DOI":"10.1016\/j.addr.2021.113888","article-title":"Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis.","volume":"176","author":"Kumar","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nrendo.2017.64","article-title":"Type 2 diabetes mellitus and psychological stress - a modifiable risk factor.","volume":"13","author":"Hackett","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"880298","DOI":"10.3389\/fimmu.2022.880298","article-title":"Association of inflammatory cytokines with non-alcoholic fatty liver disease.","volume":"13","author":"Duan","year":"2022","journal-title":"Front Immunol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3390\/metabo12050440","article-title":"Mendelian randomization analysis identifies blood tyrosine levels as a biomarker of non-alcoholic fatty liver disease.","volume":"12","author":"Gobeil","year":"2022","journal-title":"Metabolites"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/liv.15118","article-title":"Causal effects from non-alcoholic fatty liver disease on kidney function: a Mendelian randomization study.","volume":"42","author":"Park","year":"2022","journal-title":"Liver Int"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1093\/hmg\/ddy271","article-title":"Meta-analysis of genome-wide association studies for height and body mass index in~ 700000 individuals of European ancestry.","volume":"27","author":"Yengo","year":"2018","journal-title":"Hum Mol Genet"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/hmg\/ddy327","article-title":"Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry.","volume":"28","author":"Pulit","year":"2019","journal-title":"Hum Mol Genet"},{"key":"R28-20250504","first-page":"1","article-title":"Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability.","volume":"12","author":"Lagou","year":"2021","journal-title":"Nat Commun"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"e1002383","DOI":"10.1371\/journal.pmed.1002383","article-title":"Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: a transethnic genome-wide meta-analysis.","volume":"14","author":"Wheeler","year":"2017","journal-title":"PLoS Med"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/s41586-019-1310-4","article-title":"Genetic analyses of diverse populations improves discovery for complex traits.","volume":"570","author":"Wojcik","year":"2019","journal-title":"Nature"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-019-1364-z","article-title":"GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE Network.","volume":"17","author":"Namjou","year":"2019","journal-title":"BMC Med"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jhep.2020.04.003","article-title":"Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort","volume":"73","author":"Anstee","year":"2020","journal-title":"J Hepatol"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation.","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies.","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/ije\/dyy258","article-title":"Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption.","volume":"48","author":"Bowden","year":"2019","journal-title":"Int J Epidemiol"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data.","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1161\/CIRCULATIONAHA.116.026560","article-title":"Causal associations of adiposity and body fat distribution with coronary heart disease, stroke subtypes, and type 2 diabetes mellitus: a Mendelian randomization analysis.","volume":"135","author":"Dale","year":"2017","journal-title":"Circulation"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1007\/s11695-021-05470-2","article-title":"Correlation between anthropometric measurements and non-alcoholic fatty liver disease in individuals with obesity undergoing bariatric surgery: cross-sectional study.","volume":"31","author":"Reis","year":"2021","journal-title":"Obes Surg"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease.","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications.","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics.","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"R45-20250504","first-page":"15","article-title":"HbA1C as a biomarker of non-alcoholic fatty liver disease: comparison with anthropometric parameters.","volume":"9","author":"Masroor","year":"2021","journal-title":"J Clin Transl Hepatol"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12902-022-01134-z","article-title":"Association of glycated hemoglobin with non-alcoholic fatty liver disease patients and the severity of liver steatosis and fibrosis measured by transient elastography in adults without diabetes.","volume":"22","author":"Xie","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/jdi.13455","article-title":"Mean and visit-to-visit variability of glycated hemoglobin, and the risk of non-alcoholic fatty liver disease.","volume":"12","author":"Yoo","year":"2021","journal-title":"J Diabetes Investig"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"BSR20193996","DOI":"10.1042\/BSR20193996","article-title":"HbA1c may contribute to the development of non-alcoholic fatty liver disease even at normal-range levels.","volume":"40","author":"Chen","year":"2020","journal-title":"Biosci Rep"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"742465","DOI":"10.3389\/fphar.2021.742465","article-title":"Preclinical evidence of berberine on non-alcoholic fatty liver disease: a systematic review and meta-analysis of animal studies.","volume":"12","author":"Ren","year":"2021","journal-title":"Front Pharmacol"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jhep.2020.03.006","article-title":"Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping.","volume":"73","author":"Liu","year":"2020","journal-title":"J Hepatol"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"3465980","DOI":"10.1155\/2022\/3465980","article-title":"Lifestyle intervention for patients with nonalcoholic fatty liver disease: a randomized clinical trial based on the theory of planned behavior.","volume":"2022","author":"Mobasheri","year":"2022","journal-title":"Biomed Res Int"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"100256","DOI":"10.1016\/j.jhepr.2021.100256","article-title":"Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial.","volume":"3","author":"Holmer","year":"2021","journal-title":"JHEP Rep"},{"key":"R53-20250504","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M22-1787","article-title":"Effect of calorie-unrestricted low-carbohydrate, high-fat diet versus high-carbohydrate, low-fat diet on type 2 diabetes and nonalcoholic fatty liver disease: a randomized controlled trial.","volume":"176","author":"Hansen","year":"2023","journal-title":"Ann Intern Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034638","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:34:30Z","timestamp":1746326070000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,22]]},"references-count":53,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034638","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,22]]}}}